3 búsqueda de la palabra clave 'prevalence'

Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: a Systematic Review / Fabián Juliao Baños    

Público ISBD Título : Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: a Systematic Review Tipo de documento : documento electrónico Autores : Fabián Juliao Baños, Fecha de publicación : 2020 Títulos uniformes : Clinical Gastroenterology and Hepatology Idioma : Inglés (eng) Palabras clave : Anti-TNF  ethnicity  incidence  inflammatory bowel disease  prevalence  race  risk factor Resumen : Background & Aims: The incidence of inflammatory bowel diseases (IBD) is increasing in Latin America. We performed a systematic review to identify clinical and epidemiologic features of IBD in Latin America (including Mexico, Central America, and South America) and the Caribbean. Methods: We searched MEDLINE, EMBASE, and SciELO databases for clinical or epidemiologic studies of Crohn’s disease (CD) or ulcerative colitis (UC) from Latin American and Caribbean countries and territories that reported incidence, prevalence, ratio of UC:CD, IBD phenotype, and treatment, through September 12, 2018. Data were extracted from 61 articles for analysis. Results: The incidence and prevalence of IBD have been steadily increasing in Latin America and the Caribbean. The incidence of CD in Brazil increased from 0.08 per 100,000 person-years in 1988 to 0.68 per 100,000 person-years in 1991–1995 to 5.5 per 100,000 person-years in 2015. The highest reported prevalence of IBD was in Argentina, in 2007, at 15 and 82 per 100,000 person-years for CD and UC, respectively. The ratio of UC:CD exceeded 1 in all regions throughout Latin America and the Caribbean with the exception of Brazil. Treatment with tumor necrosis factor antagonists increased steadily for patients with CD (43.4% of all patients in Brazil were treated in 2014) but less so for patients with UC (4.5% of all patients were treated in 2014). Surgery for IBD decreased with time. In Chile, surgeries were performed on 57.0% of patients with CD and 18.0% of patients with UC during the period of 1990–2002; these values decreased to 38.0% and 5.0%, respectively, during the period of 2012–2015. In Peru, 6.9% of patients with UC received colectomies in the period of 2001–2003 and 6.2% in 2004–2014. Conclusions: In a systematic review, we found the incidence of IBD to be increasing throughout Latin America and the Caribbean. Population-based epidemiology studies are needed to evaluate the increase in IBD in these regions, which differ from other global regions in climate, culture, demographics, diet, healthcare delivery and infrastructure, and socioeconomic status. Mención de responsabilidad : Paulo Gustavo Kotze, Fox E Underwood, Aderson Omar Mourão Cintra Damião, Jose Geraldo P Ferraz, Rogerio Saad-Hossne, Martin Toro, Beatriz Iade, Francisco Bosques-Padilla, Fábio Vieira Teixeira, Fabian Juliao-Banos, Daniela Simian, Subrata Ghosh, Remo Panaccione, Siew C Ng, Gilaad G Kaplan Referencia : Clin Gastroenterol Hepatol. 2020 Feb;18(2):304-312. DOI (Digital Object Identifier) : 10.1016/j.cgh.2019.06.030 PMID : 31252191 Derechos de uso : CC BY-NC-ND En línea : https://www.cghjournal.org/article/S1542-3565(19)30668-8/fulltext Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4244 Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: a Systematic Review [documento electrónico] / Fabián Juliao Baños,  . - 2020. Obra : Clinical Gastroenterology and Hepatology Idioma : Inglés (eng) Palabras clave : Anti-TNF  ethnicity  incidence  inflammatory bowel disease  prevalence  race  risk factor Resumen : Background & Aims: The incidence of inflammatory bowel diseases (IBD) is increasing in Latin America. We performed a systematic review to identify clinical and epidemiologic features of IBD in Latin America (including Mexico, Central America, and South America) and the Caribbean. Methods: We searched MEDLINE, EMBASE, and SciELO databases for clinical or epidemiologic studies of Crohn’s disease (CD) or ulcerative colitis (UC) from Latin American and Caribbean countries and territories that reported incidence, prevalence, ratio of UC:CD, IBD phenotype, and treatment, through September 12, 2018. Data were extracted from 61 articles for analysis. Results: The incidence and prevalence of IBD have been steadily increasing in Latin America and the Caribbean. The incidence of CD in Brazil increased from 0.08 per 100,000 person-years in 1988 to 0.68 per 100,000 person-years in 1991–1995 to 5.5 per 100,000 person-years in 2015. The highest reported prevalence of IBD was in Argentina, in 2007, at 15 and 82 per 100,000 person-years for CD and UC, respectively. The ratio of UC:CD exceeded 1 in all regions throughout Latin America and the Caribbean with the exception of Brazil. Treatment with tumor necrosis factor antagonists increased steadily for patients with CD (43.4% of all patients in Brazil were treated in 2014) but less so for patients with UC (4.5% of all patients were treated in 2014). Surgery for IBD decreased with time. In Chile, surgeries were performed on 57.0% of patients with CD and 18.0% of patients with UC during the period of 1990–2002; these values decreased to 38.0% and 5.0%, respectively, during the period of 2012–2015. In Peru, 6.9% of patients with UC received colectomies in the period of 2001–2003 and 6.2% in 2004–2014. Conclusions: In a systematic review, we found the incidence of IBD to be increasing throughout Latin America and the Caribbean. Population-based epidemiology studies are needed to evaluate the increase in IBD in these regions, which differ from other global regions in climate, culture, demographics, diet, healthcare delivery and infrastructure, and socioeconomic status. Mención de responsabilidad : Paulo Gustavo Kotze, Fox E Underwood, Aderson Omar Mourão Cintra Damião, Jose Geraldo P Ferraz, Rogerio Saad-Hossne, Martin Toro, Beatriz Iade, Francisco Bosques-Padilla, Fábio Vieira Teixeira, Fabian Juliao-Banos, Daniela Simian, Subrata Ghosh, Remo Panaccione, Siew C Ng, Gilaad G Kaplan Referencia : Clin Gastroenterol Hepatol. 2020 Feb;18(2):304-312. DOI (Digital Object Identifier) : 10.1016/j.cgh.2019.06.030 PMID : 31252191 Derechos de uso : CC BY-NC-ND En línea : https://www.cghjournal.org/article/S1542-3565(19)30668-8/fulltext Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4244

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001224	AC-2019-013	Archivo digital	Producción Científica	Artículos científicos	Disponible

Documentos electrónicos

2019-013.pdf Adobe Acrobat PDF

Delirium during the first evaluation of children aged five to 14 years admitted to a paediatric critical care unit / Mussatyé Elorza Parra ; Katerine Uribe Hernández  

Público ISBD Título : Delirium during the first evaluation of children aged five to 14 years admitted to a paediatric critical care unit Tipo de documento : documento electrónico Autores : Mussatyé Elorza Parra, ; Katerine Uribe Hernández, Fecha de publicación : 2018 Títulos uniformes : Intensive & Critical Care Nursing Idioma : Inglés (eng) Palabras clave : Critical care  delirium  nursing diagnosis  prevalence Resumen : Objectives: To describe the prevalence and characteristics of delirium during the initial evaluation of critically ill patients aged 5–14 years. Method/design: This is a cross-sectional descriptive study in a critical care unit. For six months, all patients were evaluated within the first 24–72 hours or when sedation permitted the use of the paediatric confusion assessment method for the intensive care unit (PCAM-ICU) and the Delirium Rating Scale-Revised-98 items #7 and #8 to determine motor type. We report the characteristics of PCAM-ICU delirium (at least three of the required items scored positive) and of subthreshold score cases (two positive items). Results: Of 77 admissions, 15 (19.5%) had delirium, and 11 (14.2%) were subthreshold. A total of 53.3% of delirium and 45.5% of subthreshold cases were hypoactive. The prevalence of delirium and subthreshold PCAM-ICU was 83.3% and 16.7% in mechanically ventilated children. The most frequent combination of PCAM-ICU alterations in subthreshold cases was acute onset-fluctuation with altered alertness. The main nursing diagnoses were related to reduced cellular respiration. Conclusions: Delirium is common in critically ill children. It is necessary to assess whether certain nursing diagnoses imply an increase in delirium. Longitudinal studies of subthreshold PCAM-ICU cases are needed to understand their importance better. Mención de responsabilidad : Eliana María Cano Londoño, Isabel Cristina Mejía Gil, Katerine Uribe Hernández, Carmenza Alexandra Ricardo Ramírez, Matilde Ligia Álvarez Gómez, Ricardo Antonio Consuegra Peña, Camilo Andrés Agudelo Vélez, Susana Zuluaga Penagos, Mussatye Elorza Parra, José G Franco Vásquez Referencia : Intensive Crit Care Nurs. 2018 Apr;45:37-43. DOI (Digital Object Identifier) : 10.1016/j.iccn.2017.12.010 PMID : 29428252 En línea : https://linkinghub.elsevier.com/retrieve/pii/S0964339717300678 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4108 Delirium during the first evaluation of children aged five to 14 years admitted to a paediatric critical care unit [documento electrónico] / Mussatyé Elorza Parra, ; Katerine Uribe Hernández,  . - 2018. Obra : Intensive & Critical Care Nursing Idioma : Inglés (eng) Palabras clave : Critical care  delirium  nursing diagnosis  prevalence Resumen : Objectives: To describe the prevalence and characteristics of delirium during the initial evaluation of critically ill patients aged 5–14 years. Method/design: This is a cross-sectional descriptive study in a critical care unit. For six months, all patients were evaluated within the first 24–72 hours or when sedation permitted the use of the paediatric confusion assessment method for the intensive care unit (PCAM-ICU) and the Delirium Rating Scale-Revised-98 items #7 and #8 to determine motor type. We report the characteristics of PCAM-ICU delirium (at least three of the required items scored positive) and of subthreshold score cases (two positive items). Results: Of 77 admissions, 15 (19.5%) had delirium, and 11 (14.2%) were subthreshold. A total of 53.3% of delirium and 45.5% of subthreshold cases were hypoactive. The prevalence of delirium and subthreshold PCAM-ICU was 83.3% and 16.7% in mechanically ventilated children. The most frequent combination of PCAM-ICU alterations in subthreshold cases was acute onset-fluctuation with altered alertness. The main nursing diagnoses were related to reduced cellular respiration. Conclusions: Delirium is common in critically ill children. It is necessary to assess whether certain nursing diagnoses imply an increase in delirium. Longitudinal studies of subthreshold PCAM-ICU cases are needed to understand their importance better. Mención de responsabilidad : Eliana María Cano Londoño, Isabel Cristina Mejía Gil, Katerine Uribe Hernández, Carmenza Alexandra Ricardo Ramírez, Matilde Ligia Álvarez Gómez, Ricardo Antonio Consuegra Peña, Camilo Andrés Agudelo Vélez, Susana Zuluaga Penagos, Mussatye Elorza Parra, José G Franco Vásquez Referencia : Intensive Crit Care Nurs. 2018 Apr;45:37-43. DOI (Digital Object Identifier) : 10.1016/j.iccn.2017.12.010 PMID : 29428252 En línea : https://linkinghub.elsevier.com/retrieve/pii/S0964339717300678 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4108

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000719	AC-2018-006	Archivo digital	Producción Científica	Artículos científicos	Disponible

Hepatitis C virus seroprevalence in multi-transfused patients in Colombia / Sergio Jaramillo Velásquez ; Jorge Hernando Donado Gómez ; Ángela Patricia Estrada Naranjo ; Sandra Yepes  

Público ISBD Título : Hepatitis C virus seroprevalence in multi-transfused patients in Colombia Tipo de documento : documento electrónico Autores : Sergio Jaramillo Velásquez, ; Jorge Hernando Donado Gómez, ; Ángela Patricia Estrada Naranjo, ; Sandra Yepes, Fecha de publicación : 2005 Títulos uniformes : Journal of Clinical Virology Idioma : Inglés (eng) Palabras clave : HCV  prevalence  multi-transfused patients  Colombia Resumen : Background: Hepatitis C Vtrus (HCV) refection is a public health problem worldwide, with particular relevance m multi-transfused patients given that HCV is principally transmitted by exposure to infected blood Study design: Between February and September 2003 a cross-sectional study was carried out m four hospital centres m Bogotfi and Medellln, Colombia, to determine the risk factors for HCV refection m 500 multi-transfused patients. Results: The study population was distributed in five groups haemophlha, haemodyahsls, acute bleeding, oncologlcal illnesses and sickle cell disease or thalassemla Serum samples from patients were tested for HCV aXltlbodles (Asxym TM, Abbott) An overall prevalence (9 0%, 95% confidence interval (CI) 6 4 11 6) (45/500) of HCV infection was found Antl-HCV aXltlbodles were detected m 32 2% of patients with haemophlha, 6 1% of patients undergoing haemodlalysls, 7 1% of patients with sickle cell disease or thalassemla, 2 6% of patients with acute bleeding and 3 4% of patients with oncologlcal or hematological diseases The mare risk t; actors associated with refection by HCV were to be hemophdlc (odds ratio, OR 18 03, 95% CI 3 96 114 17), having received transfusions before 1995 (OR 12 27, 95% CI 5 57 27 69), and having received more than 48 units of blood components (OR 6 08, 95% CI 3 06 12 1) In the multlwxlate axmlysls, only the year of transfusions (before 1995) remained significantly associated with risk of infection by HCV. Conclusions: The data show a 3-fold reduction m the refection risk between 1993 and 1995, when the serological screening for HCV in blood donors was being introduced A reduction greater than 90% was achteved by 1995 when the screening coverage reached 99% Mención de responsabilidad : Mauricio Beltrân, Maria-Cristina Navas, Fernando De la Hoz, Maria Mercedes Muñoz, Sergio Jaramillo, Cecilia Estrada, Lucia Del Pilar Cortés, Maria Patricia Arbelâez, Jorge Donado, Gloria Barco, Martha Luna, Gustavo Adolfo Uribe, Amalia de Maldonado, Juan Carlos Restrepo, Gonzalo Correa, Paula Borda, Gloria Rey, Marlen de Neira, Angela Estrada, Sandra Yepes, Oscar Beltrân, Javier Pacheco, Iván Villegas, Jorge Boshell Referencia : J Clin Virol. 2005 Dec;34Suppl,2:S33-8. DOI (Digital Object Identifier) : 10.1016/S1386-6532(05)80032-0 PMID : 16461238 En línea : https://linkinghub.elsevier.com/retrieve/pii/S1386653205800320 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3438 Hepatitis C virus seroprevalence in multi-transfused patients in Colombia [documento electrónico] / Sergio Jaramillo Velásquez, ; Jorge Hernando Donado Gómez, ; Ángela Patricia Estrada Naranjo, ; Sandra Yepes,  . - 2005. Obra : Journal of Clinical Virology Idioma : Inglés (eng) Palabras clave : HCV  prevalence  multi-transfused patients  Colombia Resumen : Background: Hepatitis C Vtrus (HCV) refection is a public health problem worldwide, with particular relevance m multi-transfused patients given that HCV is principally transmitted by exposure to infected blood Study design: Between February and September 2003 a cross-sectional study was carried out m four hospital centres m Bogotfi and Medellln, Colombia, to determine the risk factors for HCV refection m 500 multi-transfused patients. Results: The study population was distributed in five groups haemophlha, haemodyahsls, acute bleeding, oncologlcal illnesses and sickle cell disease or thalassemla Serum samples from patients were tested for HCV aXltlbodles (Asxym TM, Abbott) An overall prevalence (9 0%, 95% confidence interval (CI) 6 4 11 6) (45/500) of HCV infection was found Antl-HCV aXltlbodles were detected m 32 2% of patients with haemophlha, 6 1% of patients undergoing haemodlalysls, 7 1% of patients with sickle cell disease or thalassemla, 2 6% of patients with acute bleeding and 3 4% of patients with oncologlcal or hematological diseases The mare risk t; actors associated with refection by HCV were to be hemophdlc (odds ratio, OR 18 03, 95% CI 3 96 114 17), having received transfusions before 1995 (OR 12 27, 95% CI 5 57 27 69), and having received more than 48 units of blood components (OR 6 08, 95% CI 3 06 12 1) In the multlwxlate axmlysls, only the year of transfusions (before 1995) remained significantly associated with risk of infection by HCV. Conclusions: The data show a 3-fold reduction m the refection risk between 1993 and 1995, when the serological screening for HCV in blood donors was being introduced A reduction greater than 90% was achteved by 1995 when the screening coverage reached 99% Mención de responsabilidad : Mauricio Beltrân, Maria-Cristina Navas, Fernando De la Hoz, Maria Mercedes Muñoz, Sergio Jaramillo, Cecilia Estrada, Lucia Del Pilar Cortés, Maria Patricia Arbelâez, Jorge Donado, Gloria Barco, Martha Luna, Gustavo Adolfo Uribe, Amalia de Maldonado, Juan Carlos Restrepo, Gonzalo Correa, Paula Borda, Gloria Rey, Marlen de Neira, Angela Estrada, Sandra Yepes, Oscar Beltrân, Javier Pacheco, Iván Villegas, Jorge Boshell Referencia : J Clin Virol. 2005 Dec;34Suppl,2:S33-8. DOI (Digital Object Identifier) : 10.1016/S1386-6532(05)80032-0 PMID : 16461238 En línea : https://linkinghub.elsevier.com/retrieve/pii/S1386653205800320 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3438

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000005	AC-2005-004	Archivo digital	Producción Científica	Artículos científicos	Disponible